Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Lui

Showing results (441-450 of 485) with videos related to

Pageof 49
Sort By:
Diabetes, Obesity & Metabolism|June 16, 2026
Type 2 Diabetes Is Associated With Increased Complications and Mortality After Hip Fracture in Older Adults Aged 60 Years or OlderXincheng Zou, Manju Chandran, Xi Xiong, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 8, 2020
Novel therapeutic targets in mood disorders: Pentoxifylline (PTX) as a candidate treatmentAshley N Siegel, Nelson Rodrigues, Flora Nasri, et al.
Psychopharmacology|January 23, 2021
Ketamine-induced urological toxicity: potential mechanisms and translation for adults with mood disorders receiving ketamine treatmentJason Ng, Leanna M W Lui, Joshua D Rosenblat, et al.
NPJ Digital Medicine|May 13, 2021
An artificial intelligence system for predicting the deterioration of COVID-19 patients in the emergency departmentFarah E Shamout, Yiqiu Shen, Nan Wu, et al.
Cancer Research|May 9, 2012
TMEM16A induces MAPK and contributes directly to tumorigenesis and cancer progressionUmamaheswar Duvvuri, Daniel J Shiwarski, Dong Xiao, et al.
JCO Precision Oncology|April 9, 2019
Acquired <i>ALK</i> and <i>RET</i> Gene Fusions as Mechanisms of Resistance to Osimertinib in <i>EGFR</i>-Mutant Lung CancersMichael Offin, Romel Somwar, Natasha Rekhtman, et al.
Journal of Affective Disorders|July 16, 2020
The utility of smartphone-based, ecological momentary assessment for depressive symptomsSamantha J Yim, Leanna M W Lui, Yena Lee, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|October 8, 2020
Early symptomatic improvements as a predictor of response to repeated-dose intravenous ketamine: Results from the Canadian Rapid Treatment Center of ExcellenceOrly Lipsitz, Roger S McIntyre, Nelson B Rodrigues, et al.
Infectious Diseases (London, England)|March 14, 2022
Registered clinical trials investigating treatment of long COVID: a scoping review and recommendations for researchFelicia Ceban, Alexia Leber, Muhammad Youshay Jawad, et al.
Journal of Psychiatric Research|June 18, 2023
Glucagon-like peptide 1 (GLP-1) receptor agonists as a protective factor for incident depression in patients with diabetes mellitus: A systematic reviewDaniel H Cooper, Ranuk Ramachandra, Felicia Ceban, et al.
Pageof 49

Showing results (441-450 of 485) with videos related to

Sort By:
Pageof 49
Diabetes, Obesity & Metabolism|June 16, 2026
Type 2 Diabetes Is Associated With Increased Complications and Mortality After Hip Fracture in Older Adults Aged 60 Years or OlderXincheng Zou, Manju Chandran, Xi Xiong, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 8, 2020
Novel therapeutic targets in mood disorders: Pentoxifylline (PTX) as a candidate treatmentAshley N Siegel, Nelson Rodrigues, Flora Nasri, et al.
Psychopharmacology|January 23, 2021
Ketamine-induced urological toxicity: potential mechanisms and translation for adults with mood disorders receiving ketamine treatmentJason Ng, Leanna M W Lui, Joshua D Rosenblat, et al.
NPJ Digital Medicine|May 13, 2021
An artificial intelligence system for predicting the deterioration of COVID-19 patients in the emergency departmentFarah E Shamout, Yiqiu Shen, Nan Wu, et al.
Cancer Research|May 9, 2012
TMEM16A induces MAPK and contributes directly to tumorigenesis and cancer progressionUmamaheswar Duvvuri, Daniel J Shiwarski, Dong Xiao, et al.
JCO Precision Oncology|April 9, 2019
Acquired <i>ALK</i> and <i>RET</i> Gene Fusions as Mechanisms of Resistance to Osimertinib in <i>EGFR</i>-Mutant Lung CancersMichael Offin, Romel Somwar, Natasha Rekhtman, et al.
Journal of Affective Disorders|July 16, 2020
The utility of smartphone-based, ecological momentary assessment for depressive symptomsSamantha J Yim, Leanna M W Lui, Yena Lee, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|October 8, 2020
Early symptomatic improvements as a predictor of response to repeated-dose intravenous ketamine: Results from the Canadian Rapid Treatment Center of ExcellenceOrly Lipsitz, Roger S McIntyre, Nelson B Rodrigues, et al.
Infectious Diseases (London, England)|March 14, 2022
Registered clinical trials investigating treatment of long COVID: a scoping review and recommendations for researchFelicia Ceban, Alexia Leber, Muhammad Youshay Jawad, et al.
Journal of Psychiatric Research|June 18, 2023
Glucagon-like peptide 1 (GLP-1) receptor agonists as a protective factor for incident depression in patients with diabetes mellitus: A systematic reviewDaniel H Cooper, Ranuk Ramachandra, Felicia Ceban, et al.
Pageof 49